In late April 2026, Boston Scientific reported quarterly revenue of US$5.20 billion, up 11.6% year on year and ahead of expectations, but cut near-term and full-year guidance amid intensifying cardiac ...
Original Image Link
Source:finance.yahoo.com
Original Image Link
Source:finance.yahoo.com
Posted: 2026-06-05 10:29:00

















